翔宇医疗
(688626)
| 流通市值：63.78亿 | | | 总市值：63.78亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 373,167,985.72 | 193,080,689.91 | 767,747,443.44 | 537,029,843.94 |
| 营业总成本 | 343,483,933.6 | 168,290,426.45 | 726,616,071.69 | 520,270,525.26 |
| 其他经营收益 | | | | |
| 营业利润 | 43,538,901.59 | 26,710,445.43 | 76,708,516.65 | 45,577,959.43 |
| 利润总额 | 43,363,665.1 | 26,666,187.38 | 74,431,576.93 | 44,305,425.87 |
| 净利润 | 39,894,339.69 | 24,899,960.92 | 75,986,946.04 | 41,907,442.75 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 39,894,339.69 | 24,899,960.92 | 75,986,946.04 | 41,907,442.75 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,446,441,376.52 | 1,597,126,057.21 | 1,486,296,113.77 | 1,306,173,870.98 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,849,701,911.98 | 1,771,869,531.86 | 1,781,424,055.86 | 1,966,023,272.89 |
| 资产总计 | 3,296,143,288.5 | 3,368,995,589.07 | 3,267,720,169.63 | 3,272,197,143.87 |
| 流动负债: | | | | |
| 流动负债合计 | 901,617,690.47 | 952,170,510.15 | 950,836,051.68 | 1,039,254,590.05 |
| 非流动负债: | | | | |
| 非流动负债合计 | 283,623,734.46 | 302,325,525.69 | 236,570,965.5 | 192,191,627.2 |
| 负债合计 | 1,185,241,424.93 | 1,254,496,035.84 | 1,187,407,017.18 | 1,231,446,217.25 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,099,911,894.52 | 2,104,169,739.4 | 2,069,561,289.34 | 2,026,726,626.27 |
| 股东权益合计 | 2,110,901,863.57 | 2,114,499,553.23 | 2,080,313,152.45 | 2,040,750,926.62 |
| 负债和股东权益合计 | 3,296,143,288.5 | 3,368,995,589.07 | 3,267,720,169.63 | 3,272,197,143.87 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 475,920,384.46 | 207,172,334.11 | 1,025,863,554.04 | 693,381,715.43 |
| 经营活动现金流出小计 | 431,979,697.28 | 183,309,608.41 | 836,046,774.48 | 622,184,210.85 |
| 经营活动产生的现金流量净额 | 43,940,687.18 | 23,862,725.7 | 189,816,779.56 | 71,197,504.58 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 482,796,610.46 | 5,299,285.06 | 186,154,233.16 | 106,161,160.32 |
| 投资活动现金流出小计 | 435,960,274.92 | 72,060,678.27 | 582,442,764.89 | 401,271,437.94 |
| 投资活动产生的现金流量净额 | 46,836,335.54 | -66,761,393.21 | -396,288,531.73 | -295,110,277.62 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 530,252,156.62 | 459,752,156.62 | 808,213,403.38 | 818,500,598.9 |
| 筹资活动现金流出小计 | 559,552,050.39 | 360,708,760.73 | 621,149,084.85 | 563,361,952.21 |
| 筹资活动产生的现金流量净额 | -29,299,893.77 | 99,043,395.89 | 187,064,318.53 | 255,138,646.69 |
| 汇率变动对现金及现金等价物的影响 | 273,518.51 | 178,012.27 | -249,523.56 | -6,128.23 |
| 现金及现金等价物净增加额 | 61,750,647.46 | 56,322,740.65 | -19,656,957.2 | 31,219,745.42 |
| 期末现金及现金等价物余额 | 745,006,242.69 | 739,578,335.88 | 683,255,595.23 | 734,132,297.85 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 61,750,647.46 | - | -19,656,957.2 | - |
最新报告期：2026-09-04| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国信证券 | 凌珑,彭思宇,陈曦炳 | 0.67 | 0.83 | 1.00 | 2026-09-04 |